title: Comorbidity of eating disorders with bipolar disorder and treatment implications.
abstract: OBJECTIVE
  To review the scientific evidence examining the comorbidity among eating disorders and bipolar disorder (BD).
  
  
  METHODS
  We reviewed all published English-language studies addressing the comorbidity of anorexia nervosa, bulimia, bulimia nervosa, and binge eating disorder in patients with BD and studies of comorbidity of BD in patients with eating disorders. In addition, we discuss the pharmacologic treatment implications from reviewed studies of agents used in BD and eating disorders.
  
  
  RESULTS
  Community and clinical population studies of the lifetime prevalence rates of eating disorders in patients with BD, and of BD in patients with eating disorders, particularly when subthreshold and spectrum manifestations of these disorders are included, indicate high rates of comorbidity among these illnesses.
  
  
  CONCLUSIONS
  Pharmacologic treatment approaches to patients with BD and a co-occurring eating disorder require examination of the possible adverse effects of the treatment of each syndrome on the other and attempts to manage both syndromes with agents that might be beneficial to both.
authors.affiliation: Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. susan.mcelroy@uc.edu
authors.forename: Susan L
authors.initials: SL
authors.lastname: McElroy
authors.forename: Renu
authors.initials: R
authors.lastname: Kotwal
authors.forename: Paul E
authors.initials: PE
authors.lastname: Keck
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000453:epidemiology*; D015897:Comorbidity; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000188:drug therapy / Q000453:epidemiology; D001068:Feeding and Eating Disorders / Q000188:drug therapy* / Q000453:epidemiology*; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D000077236:Topiramate; D000078305:Zonisamide
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D007555:Isoxazoles; D000077236:Topiramate; D005632:Fructose; D000078305:Zonisamide